Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0A2RI
|
|||
Drug Name |
PMID26815044-Compound-127
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Albinism [ICD-11: EC23.2; ICD-10: E70.3, H90.3] | Patented | [1] | |
Ephelides [ICD-11: ED61.0] | Patented | [1] | ||
Melasma [ICD-11: ED60.1] | Patented | [1] | ||
Menkes disease [ICD-11: 5C64.0; ICD-10: E83.0] | Patented | [1] | ||
Senile lentigines [ICD-11: ED61.0] | Patented | [1] | ||
Structure |
Download2D MOL |
|||
Formula |
C22H22O3
|
|||
Canonical SMILES |
COC1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3)OCCO
|
|||
InChI |
1S/C22H22O3/c1-24-21-14-12-20(13-15-21)22(25-17-16-23,18-8-4-2-5-9-18)19-10-6-3-7-11-19/h2-15,23H,16-17H2,1H3
|
|||
InChIKey |
JOXFVFZKGOUGOT-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Tyrosinase (TYR) | Target Info | Inhibitor | [1] |
Target's Patent Info | Tyrosinase (TYR) | Target's Patent Info | [1] | |
BioCyc | (S)-reticuline biosynthesis | |||
Eumelanin biosynthesis | ||||
L-dopachrome biosynthesis | ||||
KEGG Pathway | Tyrosine metabolism | |||
Riboflavin metabolism | ||||
Metabolic pathways | ||||
Melanogenesis | ||||
Pathwhiz Pathway | Riboflavin Metabolism | |||
Tyrosine Metabolism | ||||
WikiPathways | Dopamine metabolism |
References | Top | |||
---|---|---|---|---|
REF 1 | Tyrosinase inhibitors: a patent review (2011-2015).Expert Opin Ther Pat. 2016;26(3):347-62. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.